143 related articles for article (PubMed ID: 32571711)
61. Impact of very early introduction of everolimus on liver regeneration after partial liver transplantation in rats.
Hirata M; Yagi S; Ito T; Masano Y; Miyachi Y; Yao S; Sonoda M; Masuda S; Haga H; Hatano E
J Hepatobiliary Pancreat Sci; 2023 Jul; 30(7):882-892. PubMed ID: 36707057
[TBL] [Abstract][Full Text] [Related]
62. 5-year follow-up of a randomized clinical study comparing everolimus plus reduced-dose cyclosporine with mycophenolate mofetil plus standard-dose cyclosporine in de novo kidney transplantation: Retrospective single center assessment.
Hiramitsu T; Okada M; Futamura K; Yamamoto T; Tsujita M; Goto N; Narumi S; Watarai Y; Takeda A; Iwasaki K; Uchida K; Kobayashi T
Int Immunopharmacol; 2016 Oct; 39():192-198. PubMed ID: 27491025
[TBL] [Abstract][Full Text] [Related]
63. mTOR inhibitors in pediatric liver transplant recipients.
Dumortier J; Couchonnal E; Lacaille F; Rivet C; Debray D; Boillot O; Lachaux A; Ackermann O; Gonzales E; Wildhaber BE; Jacquemin E; McLin V
Clin Res Hepatol Gastroenterol; 2019 Aug; 43(4):403-409. PubMed ID: 30528864
[TBL] [Abstract][Full Text] [Related]
64. Effect of everolimus vs calcineurin inhibitors on quality of life in heart transplant recipients during a 3-year follow-up: Results of a randomized controlled trial (SCHEDULE).
Relbo Authen A; Grov I; Karason K; Gustafsson F; Eiskjaer H; Rådegran G; Gude E; Jansson K; Dellgren G; Solbu D; Arora S; Andreassen AK; Gullestad L
Clin Transplant; 2017 Sep; 31(9):. PubMed ID: 28640529
[TBL] [Abstract][Full Text] [Related]
65. Optimal everolimus concentration is associated with risk reduction for acute rejection in de novo renal transplant recipients.
Chan L; Hartmann E; Cibrik D; Cooper M; Shaw LM
Transplantation; 2010 Jul; 90(1):31-7. PubMed ID: 20517177
[TBL] [Abstract][Full Text] [Related]
66. The effect of anti-thymocyte globulin and everolimus on the kinetics of cytomegalovirus viral load in seropositive kidney transplant recipients without prophylaxis.
Basso G; Felipe CR; Cristelli MP; Mansur Siliano J; Viana L; Ferreira Brigido AN; Stopa Martins SB; de Castro Lima Santos DW; Aguiar WF; Tedesco-Silva Junior H; Medina-Pestana JO
Transpl Infect Dis; 2018 Aug; 20(4):e12919. PubMed ID: 29797676
[TBL] [Abstract][Full Text] [Related]
67. Durable Clinical and Immunologic Advantage of Living Donor Liver Transplantation in Children.
Przybyszewski EM; Verna EC; Lobritto SJ; Martinez M; Vittorio JM; Fox AN; Samstein B; Kato T; Griesemer AD; Emond JC
Transplantation; 2018 Jun; 102(6):953-960. PubMed ID: 29369249
[TBL] [Abstract][Full Text] [Related]
68. Sirolimus for rescue and primary immunosuppression in transplanted children receiving tacrolimus.
Sindhi R; Webber S; Venkataramanan R; McGhee W; Phillips S; Smith A; Baird C; Iurlano K; Mazariegos G; Cooperstone B; Holt DW; Zeevi A; Fung JJ; Reyes J
Transplantation; 2001 Sep; 72(5):851-5. PubMed ID: 11571449
[TBL] [Abstract][Full Text] [Related]
69. Use of Everolimus in Liver Transplantation: Recommendations From a Working Group.
De Simone P; Fagiuoli S; Cescon M; De Carlis L; Tisone G; Volpes R; Cillo U;
Transplantation; 2017 Feb; 101(2):239-251. PubMed ID: 27495768
[TBL] [Abstract][Full Text] [Related]
70. Everolimus with low-dose tacrolimus in simultaneous pancreas and kidney transplantation.
Sageshima J; Ciancio G; Chen L; Dohi T; El-Hinnawi A; Paloyo S; Misawa R; Ekwenna O; Yatawatta A; Burke GW
Clin Transplant; 2014 Jul; 28(7):797-801. PubMed ID: 24779669
[TBL] [Abstract][Full Text] [Related]
71. The Effect of Immunosuppression on Coagulation After Liver Transplantation.
Bedreli S; Straub K; Achterfeld A; Willuweit K; Katsounas A; Saner F; Wedemeyer H; Herzer K
Liver Transpl; 2019 Jul; 25(7):1054-1065. PubMed ID: 31021493
[TBL] [Abstract][Full Text] [Related]
72. Assessing the role of everolimus in reducing hepatocellular carcinoma recurrence after living donor liver transplantation for patients within the UCSF criteria: re-inventing the role of mammalian target of rapamycin inhibitors.
Thorat A; Jeng LB; Yang HR; Yeh CC; Hsu SC; Chen TH; Poon KS
Ann Hepatobiliary Pancreat Surg; 2017 Nov; 21(4):205-211. PubMed ID: 29264583
[TBL] [Abstract][Full Text] [Related]
73. Outcomes of Early Conversion From Prograf to Generic Tacrolimus in Adult Living Donor Liver Transplant Recipients.
Kim SH; Lee SD; Kim YK; Park SJ
Transplant Proc; 2015; 47(6):1915-6. PubMed ID: 26293073
[TBL] [Abstract][Full Text] [Related]
74. Graft fibrosis in patients with biliary atresia after pediatric living-related liver transplantation.
Ueno T; Tanaka N; Ihara Y; Takama Y; Yamada H; Mushiake S; Fukuzawa M
Pediatr Transplant; 2011 Aug; 15(5):470-5. PubMed ID: 21771230
[TBL] [Abstract][Full Text] [Related]
75. Safety and Efficacy of Once-Daily Prolonged-Release Tacrolimus in Living Donor Liver Transplantation: An Open-Label, Prospective, Single-Arm, Phase 4 Study.
Lee EC; Kim SH; Park SJ
Ann Transplant; 2018 Oct; 23():713-720. PubMed ID: 30310047
[TBL] [Abstract][Full Text] [Related]
76. Effectiveness of sirolimus in combination with cyclosporine against chronic rejection in a pediatric liver transplant patient.
Shinke H; Hashi S; Kinoshita R; Taniguchi R; Sugimoto M; Matsubara K; Ogawa E; Sonoda M; Takada N; Yoshizawa A; Ogawa K; Okamoto S; Uemoto S; Masuda S
Biol Pharm Bull; 2013; 36(7):1221-5. PubMed ID: 23676788
[TBL] [Abstract][Full Text] [Related]
77. Cost-effectiveness of everolimus plus reduced tacrolimus in de novo liver-recipients in the Italian setting.
Bianic F; Campbell R; Damera V; De Simone P; Roccia A; Gregson J; Ricci JF
J Med Econ; 2016 Sep; 19(9):866-73. PubMed ID: 27081739
[TBL] [Abstract][Full Text] [Related]
78. Everolimus Is Associated With Less Weight Gain Than Tacrolimus 2 Years After Liver Transplantation: Results of a Randomized Multicenter Study.
Charlton M; Rinella M; Patel D; McCague K; Heimbach J; Watt K
Transplantation; 2017 Dec; 101(12):2873-2882. PubMed ID: 28817434
[TBL] [Abstract][Full Text] [Related]
79. Sirolimus for pediatric liver transplant recipients with post-transplant lymphoproliferative disease and hepatoblastoma.
Jiménez-Rivera C; Avitzur Y; Fecteau AH; Jones N; Grant D; Ng VL
Pediatr Transplant; 2004 Jun; 8(3):243-8. PubMed ID: 15176961
[TBL] [Abstract][Full Text] [Related]
80. Rescue FK506 early conversion for refractory rejection after pediatric liver transplantation: experience in 20 children.
Reggiani P; Gridelli B; Colledan M; Rossi G; Lucianetti A; Galmarini D; Fassati LR
Transpl Int; 1998; 11 Suppl 1():S272-4. PubMed ID: 9664995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
